Contrary to popular opinion, people aren’t keeping mum about their use of BOTOX® Cosmetic and hyaluronic acid dermal fillers, according to a survey released by The Aesthetic Surgery Education & Research Foundation (ASERF).
The research arm of the American Society for Aesthetic Plastic Surgery (ASAPS) reported that nearly nine out of 10 respondents (87%) openly discuss their BOTOX® Cosmetic and hyaluronic acid dermal filler treatments with others, with seven out of ten receiving support from the people they told.
“In a similar survey issued four years ago, we dispelled the myth that Hollywood and corporate wives were the typical BOTOX® Cosmetic patient,” said ASERF President Laurie Casas, MD, a plastic surgeon practicing in suburban Chicago. “Now, demographic and perception data trends show us that aesthetic injectable treatments have continued to evolve into mainstream and accepted options for the everyday woman.”
Further findings revealed that the typical aesthetic injectable patient is a married, working mother between 41-55 years of age with a household income of under $100,000. Nearly seven out of 10 respondents indicated that BOTOX® Cosmetic (72%) and hyaluronic acid dermal fillers (6 %) are important parts of their aesthetic routine. Seventy-two percent of respondents received BOTOX® Cosmetic injections to treat their glabellar lines, while 63 percent of those surveyed received hyaluronic acid dermal filler injections to treat their nasolabial folds.
The survey consisted of a two-page questionnaire designed by ASERF in conjunction with Industry Insights. It was distributed to 1,818 ASAPS members in March 2009 to distribute to their BOTOX® Cosmetic and/or hyaluronic acid dermal filler patients. A total of 687 completed and useable forms were received in time for processing and analysis.
[Source: Original press release]